Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6364 |
Desfesoterodine
5-HMT,(R)-5-Hydroxymethyl Tolterodine,(R)-5-羟甲基托特罗定,PNU-200577,5-HM,5-hydroxymethyl Tolterodine |
AChR | Neuroscience |
Desfesoterodine (5-HMT) 是选择性毒蕈碱受体拮抗剂,Kb 和pA2分别为 0.84 nM 和 9.14。它可改善大鼠脑梗死诱导膀胱过度活动,是 Tolterodine 和 Fesoterodine 的主要药理活性代谢产物。 | |||
T40161 |
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride,(Rac)-PNU-200577hydrochloride,(Rac)-Desfesoterodine hydrochloride |
||
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride, also known as (Rac)-Desfesoterodine hydrochloride, is an active metabolite of Tolterodine that functions as a mAChR antagonist. It exhibits significant affinity (K i values) for M1, M2, M3, M4, and M5 receptors, with values of 2.3 nM, 2 nM, 2.5 nM, 2.8 nM, and 2.9 nM, respectively. This compound is commonly employed in research related to overactive bladder conditions. | |||
T66168 | (Rac)-5-Hydroxymethyl Tolterodine | ||
(Rac)-5-Hydroxymethyl Tolterodine 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T66168,CAS号为 200801-70-3。 | |||
T1475 |
Fesoterodine fumarate
Toviaz,SPM 907,富马酸非索罗定 |
AChR | Neuroscience |
Fesoterodine fumarate (Toviaz) 是可口服的,非亚型选择性的竞争性毒蕈碱受体拮抗剂,用于膀胱过度活动症,对 M1、M2、M3、M4 和 M5 受体的pKi 值分别为 8.0、7.7、7.4、7.3 和 7.5。 |